Transient ischemic attack: Difference between revisions
Jump to navigation
Jump to search
imported>Subpagination Bot m (Add {{subpages}} and remove any categories (details)) |
imported>Robert Badgett m (→Expedited cre protocol: fixed typo) |
||
| Line 14: | Line 14: | ||
Carotid endarterectomy may prevent stroke in patients with more than 70% stenosis of the carotid artery.<ref name="pmid1852179">{{cite journal |author= |title=Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators |journal=N. Engl. J. Med. |volume=325 |issue=7 |pages=445–53 |year=1991 |pmid=1852179 |doi= |issn=}}</ref> | Carotid endarterectomy may prevent stroke in patients with more than 70% stenosis of the carotid artery.<ref name="pmid1852179">{{cite journal |author= |title=Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators |journal=N. Engl. J. Med. |volume=325 |issue=7 |pages=445–53 |year=1991 |pmid=1852179 |doi= |issn=}}</ref> | ||
===Expedited | ===Expedited care protocol=== | ||
A before and after comparison study found reduced mortality fell from 10% to 2% with the following protocol started the day the patient presents for medical care:<ref name="pmid17928046">{{cite journal |author=Rothwell PM, Giles MF, Chandratheva A, ''et al'' |title=Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison |journal=Lancet |volume=370 |issue=9596 |pages=1432–42 |year=2007 |pmid=17928046 |doi=10.1016/S0140-6736(07)61448-2 |issn=}}</ref> | A before and after comparison study found reduced mortality fell from 10% to 2% with the following protocol started the day the patient presents for medical care:<ref name="pmid17928046">{{cite journal |author=Rothwell PM, Giles MF, Chandratheva A, ''et al'' |title=Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison |journal=Lancet |volume=370 |issue=9596 |pages=1432–42 |year=2007 |pmid=17928046 |doi=10.1016/S0140-6736(07)61448-2 |issn=}}</ref> | ||
* "antiplatelet therapy: aspirin in patients not already on antiplatelet therapy (75 mg daily), or clopidogrel if aspirin was contraindicated" (loading dose of clopidogrel 300 mg). | * "antiplatelet therapy: aspirin in patients not already on antiplatelet therapy (75 mg daily), or clopidogrel if aspirin was contraindicated" (loading dose of clopidogrel 300 mg). | ||
Revision as of 05:51, 28 November 2007
Overview (summary)
A Transient Ischemic Attack (TIA) is a brief loss of neurologic function. In a TIA, the affected brain cells were not killed, but only transiently deprived of blood supply and the signs of what seems to be a stroke, (or black-out), pass quickly and completely. A TIA is often a warning sign of an impending stroke, however, and like a true stroke, is a neurologic emergency. None the less, a TIA is not a true stroke.
Treatment
Anti-platelet drugs
The most effective anti-platelet treatment is probably to combine aspirin, 25 mg twice a day with extended-release dipyridamole 200 mg twice a day according to the ESPRIT[1]
The combination of aspirin and clopidogrel should probably be avoided according to the MATCH[2] and CHARISMA[3] studies.
Invasive treatment
Carotid endarterectomy may prevent stroke in patients with more than 70% stenosis of the carotid artery.[4]
Expedited care protocol
A before and after comparison study found reduced mortality fell from 10% to 2% with the following protocol started the day the patient presents for medical care:[5]
- "antiplatelet therapy: aspirin in patients not already on antiplatelet therapy (75 mg daily), or clopidogrel if aspirin was contraindicated" (loading dose of clopidogrel 300 mg).
- * "In patients seen within 48 h of their event, or those seen within 7 days who were thought to be at particularly high early risk", clopidogrel (75 mg daily, to be stopped after 30 days; loading dose of clopidogrel 300 mg) was recommended in addition to aspirin."[6]
- However, as noted above combining aspirin 25 mg twice a day with extended-release dipyridamole 200 mg twice a day might be a better choice than either aspirin alone or aspirin combined with clopidogrel.
- simvastatin 40 mg daily
- "blood pressure lowering unless systolic blood pressure was below 130 mm Hg on repeated measurement (either by increases in existing medication, or by commencement of perindopril 4 mg daily with or without indapamide 1·25 mg daily)"
- anticoagulation as required
- "Brain imaging was required before starting combination antiplatelet treatment or anticoagulation after a minor stroke"
Prognosis
Patients diagnosed with a TIA are sometimes said to have had a warning for an approaching cerebrovascular accident. If the time period of blood supply impairment lasts more than a few minutes, the nerve cells of that area of the brain die and cause permanent neurologic deficit. One third of the people with TIA later have recurrent TIAs and one third have a stroke due to permanent nerve cell loss.
The ABCD2 score can predict likelihood of subsequent stroke.[7][8]
The score is calculated as:
- Age ≥ 60 years = 1 point
- Blood pressure at presentation ≥ 140/90 mm Hg = 1 point
- Clinical features
- unilateral weakness = 2 points
- speech disturbance without weakness = 1 point
- Duration of attack
- ≥ 60 minutes = 2 points
- 10–59 minutes = 1 point
- Diabetes = 1 point
Interpretation of score, the risk for stroke:
- Score 0-3 (low)
- 2 day risk = 1.0%
- 7 day risk = 1.2%
- Score 4-5 (moderate)
- 2 day risk = 4.1%
- 7 day risk = 5.9%
- Score 6–7 (high)
- 2 day risk = 8.1%
- 7 day risk = 11.7%
References
- ↑ Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A (2006). "Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial". Lancet 367 (9523): 1665–73. DOI:10.1016/S0140-6736(06)68734-5. PMID 16714187. Research Blogging.
- ↑ Diener HC, Bogousslavsky J, Brass LM, et al (2004). "Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial". Lancet 364 (9431): 331–7. DOI:10.1016/S0140-6736(04)16721-4. PMID 15276392. Research Blogging.
- ↑ Bhatt DL, Fox KA, Hacke W, et al (2006). "Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events". N. Engl. J. Med. 354 (16): 1706–17. DOI:10.1056/NEJMoa060989. PMID 16531616. Research Blogging.
- ↑ (1991) "Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators". N. Engl. J. Med. 325 (7): 445–53. PMID 1852179. [e]
- ↑ Rothwell PM, Giles MF, Chandratheva A, et al (2007). "Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison". Lancet 370 (9596): 1432–42. DOI:10.1016/S0140-6736(07)61448-2. PMID 17928046. Research Blogging.
- ↑ Markus HS, Droste DW, Kaps M, et al (2005). "Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial". Circulation 111 (17): 2233–40. DOI:10.1161/01.CIR.0000163561.90680.1C. PMID 15851601. Research Blogging.
- ↑ Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al (2007). "Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack". Lancet 369 (9558): 283-92. DOI:10.1016/S0140-6736(07)60150-0. PMID 17258668. Research Blogging.
- ↑ Rothwell PM, Giles MF, Flossmann E, et al (2005). "A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack". Lancet 366 (9479): 29-36. DOI:10.1016/S0140-6736(05)66702-5. PMID 15993230. Research Blogging.